A Study of Sabatolimab in Combination With Azacitidine and Venetoclax in High or Very High Risk MDS Participants ~74 mi. (Alexandroupoli, Greece, +8 more cities) Novartis Investigative Site Myelodysplastic Syndromes azacitidine, +2 more drugs chemotherapy, +1 more type